Figure 14

Drug susceptibility between the low- and high-risk groups. (A) Difference in sensitivity to Cyclophosphamide_1512 between low- and high-risk groups. (B) Difference in drug sensitivity of Bortezomib_1191 between low- and high-risk groups. (C) Differences in drug susceptibility to Cisplatin_1005 between low- and high-risk groups. (D) Difference in Podophyllotoxin Epirubicin_1511 drug sensitivity between low- and high-risk groups. (E) Differences in AZD7762_1022 susceptibility between low- and high-risk groups. (F) Differences in drug sensitivity of Venetoclax_1909 between the low- and high-risk groups. (G) Differences in susceptibility to Doramapimod_1042 between low- and high-risk groups. (H) Difference in Vincristine_1818 susceptibility between low- and high-risk groups. (I) Difference in drug sensitivity to KU-55933_1030 between low- and high-risk groups.